CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adachi, J.
Right arrow Articles by Yokota, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adachi, J.
Right arrow Articles by Yokota, J.

Cell Growth & Differentiation, Vol 7, Issue 7 879-886, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma

J Adachi, K Ookawa, M Shiseki, T Okazaki, S Tsuchida, K Morishita and J Yokota
Biology Division, National Cancer Center Research Institute, Tokyo, Japan.

Multiple genetic alterations, including inactivation of the p53 and RB genes and loss of heterozygosity on chromosome 3p, occur commonly in small cell lung carcinoma (SCLC). To assess the biological significance of p53 inactivation in the development of SCLC, tetracycline (Tc)-inducible p53 expression plasmids were introduced into a SCLC cell line, N417, in which the p53 gene as well as the RB gene was inactivated. In the absence (induced) of Tc, cells transfected with the wild-type p53 gene formed colonies in 29-58% of those with a mutant p53 gene. However, wild-type p53 genes were expressed in 0 of 43 transfectants, whereas mutant p53 genes were expressed in 75% (36/48) of the transfectants, suggesting that the growth of SCLC cells was suppressed by the expression of the wild-type p53 gene. Thus, wild-type p53-inducible clones were further established by transfection in the presence (repressed) of Tc. The in vitro growth was significantly suppressed by the induction of wild-type p53 expression, and apoptosis but not G1 arrest was observed within 24 h of p53 induction. These results strongly suggest that the restoration of the p53 function is sufficient to suppress the growth of SCLC cells in which other genetic alterations remain uncorrected, and that growth suppression by p53 is due to induction of apoptosis but not due to induction of G1 arrest through the RB pathway.


This article has been cited by other articles:


Home page
Genes Dev.Home page
E. A. Semenova, R. Nagel, and A. Berns
Origins, genetic landscape, and emerging therapies of small cell lung cancer
Genes & Dev., July 15, 2015; 29(14): 1447 - 1462.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. D. Kamat, R. B. Shmueli, N. Connis, C. M. Rudin, J. J. Green, and C. L. Hann
Poly({beta}-amino ester) Nanoparticle Delivery of TP53 Has Activity against Small Cell Lung Cancer In Vitro and In Vivo
Mol. Cancer Ther., April 1, 2013; 12(4): 405 - 415.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Zandi, G. Selivanova, C. L. Christensen, T. A. Gerds, B. M. Willumsen, and H. S. Poulsen
PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53
Clin. Cancer Res., May 1, 2011; 17(9): 2830 - 2841.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. V. Sharma and J. Settleman
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
Genes & Dev., December 15, 2007; 21(24): 3214 - 3231.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
H. Xiao, V. Palhan, Y. Yang, and R. G. Roeder
TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes
EMBO J., March 1, 2000; 19(5): 956 - 963.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.